Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4

Alzheimers Res Ther. 2010 Oct 29;2(5):31. doi: 10.1186/alzrt55.
No abstract available